Skip to main content

Sorafenib plus GCLAM held safe in AML, MDS phase-1 study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Sorafenib plus GCLAM held safe in AML, MDS phase-1 study

User login

Username

Password

Reset your password

Type	Lead	score